Global Depression Drugs Market 2014-2018
Published: Jan 2014 No. of Pages: 52
Mail us: sales@reportsandintelligence.com Detailed report at: http://www.reportsandintelligence.com/globaldepression-drugs-2014-2018-market Website: http://www.reportsandintelligence.com
TechNavio's analysts forecast the Global Depression Drugs market to grow at a CAGR of 2.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in the number of patients suffering from depression. The Global Depression Drugs market has also been witnessing the growing awareness of depression drugs. However, the generic erosion of key blockbuster drugs could pose a challenge to the growth of this market. TechNavio's report, the Global Depression Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Depression Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space are GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Inc.Other vendors mentioned in the report are Astra Zeneca plc, Bristol Myers Squibb Co., Mallinckrodt Pharmaceuticals Inc., Sanofi Aventis S.A., and Takeda Pharmaceutical Company Ltd. Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Detailed report at: http://www.reportsandintelligence.com/globaldepression-drugs-2014-2018-market
Table of Content
01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Market Segmentation by Product Types 08. Market Segmentation by Category 09. Geographical Segmentation 10. Buying Criteria 11. Rate of Incidence and Prevalence 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Vendor Landscape 17.1 Competitive Scenario 17.1.1 Key News 17.1.2 Mergers and Acquisitions 17.2 Market Share Analysis 17.3 Other Prominent Vendors 18. Key Vendor Analysis
18.1 GlaxoSmithKline plc 18.1.1 Business Overview 18.1.2 Business Segmentation 18.1.3 Key Information 18.1.4 SWOT Analysis 18.2 Eli Lilly & Co. 18.2.1 Business Overview 18.2.2 Key Information 18.2.3 SWOT Analysis 18.3 Pfizer Inc. 18.3.1 Business Overview 18.3.2 Business Segmentation 18.3.3 Key Information 18.3.4 SWOT Analysis 18.4 Forest Laboratories Inc. 18.4.1 Business Overview 18.4.2 Key Information 18.4.3 SWOT Analysis 19. Other Reports in this Series
Get detailed TOC at: http://www.reportsandintelligence.com/globaldepression-drugs-2014-2018-market/table-of-contents
Contact Us:
Cathy Viber 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Mailto: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com/ YouTube: https://www.youtube.com/user/reportsnintelligence